EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Glucagon‐Like Peptide‐1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis‐Related Diabetes

Luke A Ephraums iD, Edward R Mignone, Kylie Lange, Ashlee Routley, Judith Morton, Emily Hopkins, Sally Chapman, Lucia Gagliardi, Michael Horowitz, Mahesh M Umapathysivam iD

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11986-11989

DOI: 10.1111/dom.71312 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 08.09.2026. Verfasst von Luke A Ephraums und 9 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrine Unit, Flinders Medical Centre, Adelaide, Australia. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GLP‐1GLP‐1 analoguecohort studyincretin physiologyincretin therapyobesity therapy

Autor:innen und Institutionen

  • Diabetes and Endocrine Unit, Flinders Medical Centre, Adelaide, Australia.
  • School of Medicine, Adelaide University, Adelaide, Australia.
  • Women and Kids Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
  • Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia.
  • Endocrine and Diabetes Unit, The Queen Elizabeth Hospital, Adelaide, Australia.

ORCID-Profile: Luke A Ephraums, Mahesh M Umapathysivam

Zitieren

APA

Ephraums, L. A., Mignone, E. R., Lange, K., Routley, A., Morton, J., Hopkins, E., Chapman, S., Gagliardi, L., Horowitz, M., & Umapathysivam, M. M. (2026). Glucagon‐Like Peptide‐1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis‐Related Diabetes. Diabetes, Obesity and Metabolism, 28(12), 11986-11989. https://doi.org/10.1111/dom.71312

Vancouver

Ephraums LA, Mignone ER, Lange K, Routley A, Morton J, Hopkins E, et al. Glucagon‐Like Peptide‐1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis‐Related Diabetes. Diabetes, Obesity and Metabolism. 2026;28(12):11986-11989. doi:10.1111/dom.71312

BibTeX
@article{Ephraums2026,
  author = {Ephraums, Luke A and Mignone, Edward R and Lange, Kylie and Routley, Ashlee and Morton, Judith and Hopkins, Emily and Chapman, Sally and Gagliardi, Lucia and Horowitz, Michael and Umapathysivam, Mahesh M},
  title = {Glucagon‐Like Peptide‐1 Receptor Agonist Use Is Associated With Improved Lung Function in Cystic Fibrosis‐Related Diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11986--11989},
  doi = {10.1111/dom.71312}
}
Kostenlos starten →